Clinical Trial Update: A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effectiveness and safety of topiramate for treating bipolar disorder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Topamax (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Bipolar Disorders, Mood Disorders | Phase 3 | Status: COMPLETED